WHO ICTRP trial
The predictive value of pharmacogenomic testing in treatment of chronic cough
ChiCTR1800014768 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800014768 |
|---|---|
| Public title | The predictive value of pharmacogenomic testing in treatment of chronic cough |
| Scientific title | Effect and mechanism of P2X receptors mediated by TRPV4 and ATP on cough hypersensitivity |
| Primary sponsor | Tongji Hospital, Tongji University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Relative factors research |
| Phase | Diagnostic New Technique Clincal Study |
| Countries | China |
| Conditions | chronic cough |
| Interventions | Case series:Nil |
| Registration date | Feb 3, 2018 |
| Target size | Case series:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: